Burnier M - Search Results

1

Blockade of the renin-angiotensin-aldosterone system: a key therapeutic strategy to reduce renal and cardiovascular events in patients with diabetes.

Burnier M, Zanchi A. Burnier M, et al. J Hypertens. 2006 Jan;24(1):11-25. doi: 10.1097/01.hjh.0000191244.91314.9d. J Hypertens. 2006. PMID: 16331093 Review.

2

Comparative cardiovascular effects of drugs used for hypertension.

Burnier M, Waeber B, Nussberger J, Brunner HR. Burnier M, et al. Drugs. 1990;39 Suppl 1:32-8. doi: 10.2165/00003495-199000391-00006. Drugs. 1990. PMID: 1968375 Review.

3

In vitro effects of DuP 753, a nonpeptide angiotensin II receptor antagonist, on human platelets and rat vascular smooth muscle cells.

Burnier M, Centeno G, Grouzmann E, Walker P, Waeber B, Brunner HR. Burnier M, et al. Am J Hypertens. 1991 May;4(5 Pt 1):438-43. doi: 10.1093/ajh/4.5.438. Am J Hypertens. 1991. PMID: 2069778

4

Treating the individual hypertensive patient: considerations on dose, sequential monotherapy and drug combinations.

Brunner HR, Ménard J, Waeber B, Burnier M, Biollaz J, Nussberger J, Bellet M. Brunner HR, et al. Among authors: burnier m. J Hypertens. 1990 Jan;8(1):3-11; discussion 13-9. doi: 10.1097/00004872-199001000-00002. J Hypertens. 1990. PMID: 2157754 Review.

5

Pharmacokinetics of angiotensin converting enzyme inhibitors.

Burnier M, Waeber B, Nussberger J, Brunner HR. Burnier M, et al. Br J Clin Pharmacol. 1989;28 Suppl 2(Suppl 2):133S-139S; discussion 140S. doi: 10.1111/j.1365-2125.1989.tb03588.x. Br J Clin Pharmacol. 1989. PMID: 2690904 Free PMC article. Review.

6

Effect of angiotensin converting enzyme inhibition in renovascular hypertension.

Burnier M, Waeber B, Nussberger J, Brunner HR. Burnier M, et al. J Hypertens Suppl. 1989 Sep;7(7):S27-31. doi: 10.1097/00004872-198909007-00006. J Hypertens Suppl. 1989. PMID: 2693654 Review.

7

Neutral endopeptidase versus angiotensin converting enzyme inhibition in essential hypertension.

Favrat B, Burnier M, Nussberger J, Lecomte JM, Brouard R, Waeber B, Brunner HR. Favrat B, et al. Among authors: burnier m. J Hypertens. 1995 Jul;13(7):797-804. J Hypertens. 1995. PMID: 7594444 Clinical Trial.

8

Studies of the renal effects of angiotensin II receptor blockade: the confounding factor of acute water loading on the action of vasoactive systems.

Burnier M, Pechère-Bertschi A, Nussberger J, Waeber B, Brunner HR. Burnier M, et al. Am J Kidney Dis. 1995 Jul;26(1):108-15. doi: 10.1016/0272-6386(95)90163-9. Am J Kidney Dis. 1995. PMID: 7611241

9

Short-term and sustained renal effects of angiotensin II receptor blockade in healthy subjects.

Burnier M, Hagman M, Nussberger J, Biollaz J, Armagnac C, Brouard R, Weber B, Brunner HR. Burnier M, et al. Hypertension. 1995 Apr;25(4 Pt 1):602-9. doi: 10.1161/01.hyp.25.4.602. Hypertension. 1995. PMID: 7721404 Clinical Trial.

10

Angiotensin II receptor antagonists and the kidney.

Burnier M, Brunner HR. Burnier M, et al. Curr Opin Nephrol Hypertens. 1994 Sep;3(5):537-45. doi: 10.1097/00041552-199409000-00011. Curr Opin Nephrol Hypertens. 1994. PMID: 7804752 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,173 results

Search Page

Filters